Back to Fjärde AP-fonden Fjärde AP-fonden

GILD

Showing 9 of 31 quarters

Position history for Fjärde AP-fondenFjärde AP-fonden's holdings in Gilead Sciences, Inc.

Yes. Fjärde AP-fonden holds 558,657 shares of GILD (Gilead Sciences), worth $83.3M, as of its Q3 2026 13F filing. It reduced the position by 110,006 shares (-16.5%) from Q2 2026. Fjärde AP-fonden has held GILD in every 13F on record since Q4 2018, 31 quarterly filings. GILD is 0.4% of Fjärde AP-fonden's reported 13F portfolio.

Current Value

$83.3M

Current Shares

558,657

Total Value Change

+$58.3M

Total Shares Change

+260,694

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Decreased
558,657
-16.4%
$83.3M0.4%$149.05
0
2026-Q2
Increased
668,663
+43.4%
$84.5M0.4%$125.63
48
2026-Q1
Increased
466,363
+58.1%
$65M0.4%$137.68
50
2025-Q4
Decreased
295,063
-1.1%
$36.2M0.3%$120.57
0
2025-Q3
Decreased
298,263
-2.7%
$33.1M0.3%$108.32
0
2025-Q2
Increased
306,463
+10.2%
$34M0.3%$107.45
38
2025-Q1
Decreased
278,163
-3.2%
$31.2M0.4%$107.83
0
2024-Q4
Decreased
287,363
-3.6%
$26.5M0.3%$88.27
0
2024-Q3
Decreased
297,963
-15.0%
$25M0.3%$79.45
0

Other major holders of GILD: BlackRock, Inc., Vanguard Group Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used